A.R.T. Advisors’s St Jude Medical STJ Stock Holding History

A.R.T. Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,900	Closed	-$2.24M	–	1927
2016 Q4	$2.24M	Buy	+27,900	New	+$2.21M	0.13%	228
2016 Q3	–	Sell	-16,168	Closed	-$1.26M	–	1516
2016 Q2	$1.26M	Buy	+16,168	New	+$1.15M	0.06%	462
2014 Q4	–	Sell	-39,923	Closed	-$2.4M	–	1838
2014 Q3	$2.4M	Buy	+39,923	New	+$2.61M	0.11%	262
2013 Q4	–	Sell	-4,648	Closed	-$249K	–	1701
2013 Q3	$249K	Buy	+4,648	New	+$239K	0.01%	1056

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

A.R.T. Advisors's STJ Position: Q1 2017 in Review

A.R.T. Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 27,900 shares — an estimated $2.24M sold.

A.R.T. Advisors first reported a position in STJ in Q3 2013 and held it in 4 quarters. The position peaked at $2.4M in Q3 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

A.R.T. Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
A.R.T. Advisors sold 27,900 St Jude Medical shares in Q1 2017, an estimated $2.24M.
A.R.T. Advisors first reported a position in St Jude Medical in Q3 2013 and held it in 4 quarters.
A.R.T. Advisors's St Jude Medical position peaked at $2.4M in Q3 2014.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on A.R.T. Advisors's 13F filing for Q1 2017, filed 15 May 2017.